All In MedTech

Device Trial Radar · NCT03474874

Human Repeated Insult Patch Test

Last checked: Nov 19, 2026Latest source record: Jul 16, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

68

Actual

Start

Feb 26, 2018

Primary completion

Apr 6, 2018

Study completion Apr 6, 2018

Sponsor

Lead sponsor
NeXtGen Biologics, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Mar 23, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 79 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Repeated insult patch test on healthy males and females to determine potential contact irritation or contact allergy in the skin

Conditions

  • Dermatitis
  • Allergy
  • Contact Allergy

Interventions

  • NeoMatriX Collagen DressingDevice

    Collagen wound dressing

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Erythema at the Patch Test Site is Evaluated for Each ParticipantTime frame: 3 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Consumer Product Testing Company, Inc.

    Fairfield, New Jersey

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.